Big Lots has announced plans to close up to 40 stores by the end of this year and two Long Island locations are on the chopping block.The Centereach location at 231 Centereach Mall and the Carle Place location at 260 Voice Road are slated for closure and currently have sales of up to 20% off.
The announcement, made in a filing to the U.S. Securities and Exchange Commission, said the discount retailer would be shuttering 35 to 40 stores as its financials worsen in a tough consumer market. The company currently operates over 1,400 stores nationwide. The other five locations on Long Island — Bay Shore, West Babylon, Hicksville, Copiague and the newly opened store in Holbrook — appear to be safe for now.
“In 2024, the U.S. economy has continued to face macroeconomic challenges including elevated inflation, which has adversely impacted the buying power of our customers,” the filing from Big Lots said. According to the financial disclosure, sales dropped 10.2% between the first quarters of 2023 and 2024, equating to a loss of about $114.5 million.
The music for 'A Cottage for Sale.' Photo courtesy of The Jazz Loft
The Jazz Loft, 275 Christian Ave., Stony Brook, recently acquired a vast collection of memorabilia from composer Larry Conley (November 29, 1895 – February 29, 1960), best known for his composition “A Cottage for Sale,” which has been recorded by more that 50 artists, including Frank Sinatra, Nat King Cole, Tony Bennett and others. Conley wrote the lyrics to the song and the music was composed by Willard Robison.
The acquisition, which was donated by Conley’s son-in-law and Jazz Loft patron Bob Lang, includes master acetates from original songs dating back to the 1920’s, original concert programs, letters, songwriting contracts, and a wealth of research material compiled over many decades by Bob. The acquisition also included funding for the care and maintenance of the collection.
The music for ‘A Cottage for Sale.’ Photo courtesy of The Jazz Loft
“We are elated to get this collection and to honor Bob Lang in the process,” said The Jazz Loft Founder Tom Manuel. “Bob was a loyal patron and supporter of The Jazz Loft. He was one of those extra special people with an encyclopedic knowledge of the history of the music. Talking to Bob was like hanging with a star musician who had been around for it all. I’m especially honored that he so appreciated The Jazz Loft and especially honored to have had the opportunity to be his friend.”
A former resident of Port Jefferson, Bob Lang died in 2022.
The story of Bob’s fascination for all things Larry Conley has its roots in a sweet love story. Bob’s wife, Hope Conley, was Larry’s daughter. She was orphaned at the young age of 16. While Hope was left with royalties from her father’s work, she did not know much about his illustrious career as a songwriter and musician. But Bob changed all of that. After the couple was married in 1966, he launched his “detective career,” looking into “all things Larry Conley.”
“Bob helped Hope to uncover resources and family members that she did not know she had,” said Virginia Tanner, who knew Bob for many years prior to his death in 2022. “Bob helped her to retrace her father’s life. They visited the town where he was born, followed research trials throughout the mid-west and eventually to St. Louis. It was there that they discovered the venues where he played, from the steamboats to the night clubs, to the theaters, to the homes of his musical collaborators. They even struck up friendships with the remaining families, exchanging Christmas cards until Bob’s last days.”
In St. Louis, Bob and Hope visited the offices of the musician’s union and found Conley’s application for his union card. Conley had a nightclub that underwent many changes from the late 20’s to the 1990’s and beyond, according to Virginia. The couple joined the New York City Sheet Music Society where Hope got to meet contemporaries of her father.
“Singers and songwriters who had known and played with Conley told them story after story, lead after lead to chase down sheet music, old records, test pressings and more,” said Virginia. “Bob was an impeccable researcher who followed every lead until he could prove it or discard it.”
Hope passed away in 2001, but Bob never stopped working on Larry’s story. The Conley music rights are now in the hands of Hope’s half-sister, Joy’s family and Larry Conley’s great grandson, Ryan.
Throughout the years, Bob and Hope amassed a tremendous collection of Larry Conley memorabilia. After Bob’s death in 2022, the collection was given to The Jazz Loft, where he had spent many enjoyable evenings listening to music. The hit song “A Cottage for Sale” remains a favorite of musicians. Willie Nelson recorded it in 2021 for his Frank Sinatra tribute album “That’s Life.”
The Larry Conley collection will be on display in the Fall of 2024 at The Jazz Loft. For more information, visit www.thejazzloft.org.
Dr. Jennifer Scott Miceli conducts the Belle Voci Intergenerational Choral Society.
Two Decades of Hope and Healing Through Music
Belle Voci Intergenerational Choral Society, a Long Island-based organization dedicated to supporting wellness, cancer prevention, and cure through choral performances, is celebrating 20 years of Sisterhood in Song with the “You Do Not Walk Alone” series. Their Rose Remembrance concert will be held on August 4 at Christ Church in Oyster Bay, and the Candlelight Remembrance concert will take place on August 9 at St. John’s Episcopal Church in Huntington.
The concerts will feature works by Carnelia, Evsenvalds, Hagenberg, Brahms, and Runestad, performed by professional and amateur singers, accompanied by pianist Alex Pryrodny, and also featuring strings, flute, brass, percussion, and harp.
Belle Voci was founded in 2004 by Dr. Jennifer Scott Miceli, Director of Long Island Sound Vocal Jazz (LISVJ) at LIU Post in Brookville, NY after losing her mother, Bonnie Scott, to cancer. Since its establishment, Belle Voci has provided a healing space for others through song. The ensemble has grown into a recognized philanthropic treble choir, offering a forum for prayer, reflection, grieving, meditation, inspiration, and celebration for both singers and audiences.
“We are thrilled to mark this milestone with performances that celebrate our musical achievements and honor those affected by cancer,” said Dr. Miceli. “Our Remembrance concerts are particularly moving, recognizing those who have passed, those living with cancer, and survivors. This year, we look forward to bringing our community together for these moments of deliverance and connection.”
In 2023, Belle Voci was named a finalist for the American Prize in Choral Performance – Community Division. The ensemble also extended its mission of cancer prevention and cure to the United Kingdom, where they performed several concerts in celebration of their 20th season promoting wellness.
Over the years, the organization has contributed tens of thousands of dollars to support wellness and cancer prevention through donations to the American Cancer Society, St. Jude Children’s Research Hospital, and Northwell Hospice Care Network.
“Our mission has always been to use the power of music to foster healing and hope,” Dr. Miceli added. “The continued support from our community has been invaluable in helping us reach more people and make a greater impact.”
Christ Church is located at 61 East Main Street in Oyster Bay.St. John’s Episcopal Church is located at 12 Prospect St. in Huntington.
Tickets are available for $30, with a discounted rate of $20 for seniors and students with ID. They can be purchased through the Belle Voci website.
About Belle Voci Intergenerational Choral Society
Belle Voci Intergenerational Choral Society (501(c)3) is a Long Island-based nonprofit philanthropic treble ensemble comprising professional singers, amateur singers, collegiate singers, school-aged singers, and music teachers with a common mission of supporting cancer prevention and cure through song. An interesting intersection of humanitarianism, musical expression, and academic rigor, Belle Voci is recognized both domestically and internationally having been the topic of local news, academic presentations, book chapters, and prestigious European performance invitations. Founded and directed by Dr. Jennifer Scott Miceli, the mission of the ensemble is to provide a forum for music teacher training, member leadership, and recognition of singers’ unique skill sets. Concert repertoire is carefully programmed for its capacity to elicit a wide range of emotions associated with the cancer journey; we aim to provide a forum where concert goers are free to experience hope, contemplation, prayer, healing, peace, and celebration through music and ritual.
Britt Burner Esq. speaks at the New York State Bar Association’s Elder Law and Special Needs Section summer meeting. Photo courtesy of Britt Burner, Esq.
Burner Prudenti Law has announced that partner Britt Burner, Esq. is the New York State Bar Association’s (NYSBA) newest Chair of the Elder Law and Special Needs Section. She kicked off her term, which officially began on June 1, 2024 and runs through May 31, 2025, at the Section’s annual meeting in Montreal held July 11-13, 2024.
The NYSBA’s Elder Law and Special Needs Section provides members with educational opportunities relating to Elder Law and Special Needs Law. The Section offers CLE (Continuing Legal Education) courses and webinars, as well as published materials on legal practice, procedure, and developments in the law. By helping to enhance the skills of lawyers who practice in this field and by providing them with opportunities for networking and knowledge sharing, the Section aims to improve the quality and efficiency of legal services offered to New Yorkers.
The Section also advocates for improvements in law and procedure that affect seniors and the disability community, in the form of studies, legal analyses and recommendations, and more. Of particular importance to Burner this year as Chair is addressing the legislative and budget concerns, especially those relating to Medicaid, that affect elder law attorneys and their clients.
With vast experience practicing as an elder law and special needs attorney, Britt Burner is well-positioned to lead the Elder Law and Special Needs Section. Before serving as an officer of the Section, she served as Vice Chair of the Section’s Medicaid Committee as well as Chair of its Legislation Committee. In addition to educating other lawyers about this area of law, Burner frequently offers seminars in the community to educate the public about elder law and special needs law as a means to help empower them to make the most informed decisions for their futures and that of their families. She is frequently honored for her contributions to the profession, having been most recently named a 2024 Super Lawyer in the field of Elder Law as well as recognized among the 2024 Best Lawyer rankings for Elder Law and Trusts & Estates in Manhattan, among numerous other awards.
The first order of business as Burner began her new term was to plan the Section’s annual meeting that was held in Montreal from July 11-13, 2024. There, she had an opportunity to share her vision for the upcoming year: increasing membership and continuing to ensure that every NYSBA elder law attorney’s concerns are heard on the state and national level.
“Serving as Chair of the New York State Bar Association Elder Law and Special Needs Section is an honor that I don’t take lightly,” shared Britt Burner, Esq. “As an elder law and special needs attorney I have personally benefited from the collective knowledge and support the Section offers, and I am thrilled to be able to pay it forward by serving as Chair.”
Stony Brook University and the Simons Foundation were recently named recipients of the Insight Into Diversity magazine 2024 Inspiring Programs in STEM Award.
Insight Into Diversity is the largest and oldest diversity and inclusion publication in higher education. The Inspiring Programs in STEM Award honors colleges and universities that encourage and assist students from underrepresented groups to enter the fields of science, technology, engineering, and mathematics (STEM). Stony Brook University and the Simons Foundation will be featured, along with 82 other recipients, in the September 2024 issue of Insight Into Diversity magazine.
“I am so proud of the cutting-edge research, outstanding teaching, and engaged scholarship and service gained from the collaboration of Stony Brook and the Simons Foundation around excellence in STEM,” said SBU Vice President for Equity and Inclusion and Chief Diversity Officer Judith Brown Clarke. “We look forward to continued partnership in our quest for deep transformational impacts that are powerful and create long-lasting changes that have a positive effect on individuals, communities, and entire societies.”
Inspiring Programs in STEM Award winners were selected by Insight Into Diversity based on efforts to inspire and encourage a new generation of young people to consider careers in STEM through mentoring, teaching, research, and successful programs and initiatives.
“I take great pride in the dedication and enthusiasm shown by our scholars and staff in initiating this program with such vigor and excellence. We are grateful for this recognition and remain dedicated to advancing the legacy we have started,” said Erwin Cabrera, executive director of the Stony Brook Simons STEM Scholars Program. “The core values of Insight Into Diversity Inspiring Programs closely resonate with the objectives of the SBU Simons STEM Scholars program, and we appreciate the opportunity to be recognized alongside other distinguished recipients.
PODS Enterprises, LLC recently released its fourth annual Moving Trends Report identifying the top 20 cities Americans are flocking to, and fleeing from, in 2024. The report analyzes consumer movements throughout the past fifteen months, identifying the environmental and economic factors that inspired these trends.
Carolinas and Appalachiansbecome new hotspots as pandemiccities cool off
For the second consecutive year, Myrtle Beach, South Carolina and Wilmington, North Carolina landed the top spot on the list of cities people are moving to. Raleigh, North Carolina jumped 14 places compared to last year, coming in sixth in 2024. However, it’s not just these coastal gems that are seeing an influx of new residents. The entire Southern Appalachian region is booming, with droves of people seeking the “quiet life” in states like Tennessee, Georgia, and Alabama.
More Americans are calling the Southeast home with the promise of lower costs of living, an exceptional quality of life, an incredible food scene, easy access to nature, and vibrant metro areas. This migration highlights the region’s broad appeal to those craving a more balanced lifestyle at a reasonable price point without sacrificing modern amenities and rich cultural experiences.
Top 20 cities with the highest number of move-ins:
1. Myrtle Beach, SC/ Wilmington, NC
2.Ocala, FL
3.Houston, TX
4.Greenville-Spartanburg, SC
5.Charlotte, NC
6.Raleigh, NC
7.Phoenix, AZ
8.Knoxville, TN
9.Jacksonville, FL
10. Asheville, NC
11. Boise, ID
12. Portland, ME
13. Nashville, TN
14. Atlanta, GA
15. Johnson City, TN
16. Huntsville, AL
17. Dover, DE
18. Orlando, FL
19. Savannah, GA
20. Greensboro, NC
“Last year, we noted the Carolinas were worth watching, and this year, they’ve not only taken the trophy as the number one spot for new moves but also broken a record,” said Rich Schwartz, SVP of Corporate Operations at PODS.
“On the flip side, we’re continuing to see a throughline where expensive metro areas are prompting Americans to flock to cities and states where the cost of living is lower, and the lifestyle is more balanced,” he added.
California dreaming turns to natural living: housing costs push Americans out of cities
Los Angeles, Northern California, South Florida’s Miami metro, and Long Island, New York continue to see the largest population exoduses. While the draw to natural surroundings is a driving force, skyrocketing costs of living have proven equally influential in this lifestyle pivot. Exorbitant housing costs, overcrowding, and hefty tax burdens have become, for some, insurmountable challenges in these urban centers. As a result, many residents find themselves priced out and seeking reprieve from major cities. This mass relocation underscores the growing appeal among Americans in prioritizing access to nature and a more sustainable quality of life over the pace of city living.
Top 20 cities with the highest number of move-outs:
1. Los Angeles, CA
2. Northern CA (San Francisco area)
3. South Florida (Miami area)
4. Long Island, NY
5. Austin, TX
6. Central Jersey, NJ
7. Chicago, IL
8. San Diego, CA
9. Stockton-Modesto, CA
10. Hudson Valley, NY
11. Santa Barbara, CA
12. Denver, CO
13. Boston, MA
14. Baltimore, MD
15. Hartford, CT
16. Portland, OR
17. Fresno, CA
18. Bakersfield, CA
19. Northern New Jersey
20. Minneapolis, MN
This article originally appeared in TBR News Media’s senior supplement Prime Times on July 18.
What is one of the most widely consumed over-the-counter drugs? Would it surprise you to hear that it’s alcohol?
There are many myths surrounding alcohol consumption. For example, you may have heard that Europeans who drink wine regularly live longer because of this. Or that only heavy drinkers need to be concerned about the resulting long-term health impacts. Both have been studied extensively.
Let’s look at what the research shows.
What’s the relationship between alcohol and cancer risk?
Alcohol is listed as a known carcinogen by the National Toxicology Program of the US Department of Health and Human Services (1). Among the research it details, it lists head and neck, esophageal, breast, liver and colorectal cancers as key cancer risks that are increased by alcohol consumption. Of these, esophageal and breast cancer risks are increased with even light drinking.
The World Health Organization reports that the International Agency for Research on Cancer classified alcohol at the highest level of carcinogen, along with asbestos, radiation, and tobacco (2).
In a January 2023 New York Times interview with Marissa Esser from the Centers for Disease Control and Prevention, she explained: “When you drink alcohol, your body metabolizes it into acetaldehyde, a chemical that is toxic to cells. Acetaldehyde both ‘damages your DNA and prevents your body from repairing the damage.’” Damaged DNA allows cells to develop into cancer tumors (3).
A meta-analysis of European studies on the effects of light to moderate alcohol use, defined as no more than two standard drinks per day, found that this level of intake caused 23,000 new cancers in the European Union in 2017 (4). Female breast cancer accounted for almost half of these.
These results support an earlier meta-analysis of 113 studies, which found there was a four percent increased risk of breast cancer with daily alcohol consumption of one drink or fewer a day (5). The authors warned that women who are at high risk of breast cancer should not drink alcohol or should drink it only occasionally.
It was also shown in the Nurses’ Health Study that drinking three to six glasses a week increased the risk of breast cancer modestly over a 28-year period (6). This study involved over 100,000 women. Even a half-glass of alcohol was associated with a 15 percent elevated risk of invasive breast cancer. The risk was dose-dependent, meaning the more participants drank in a day, the greater their risk increase. In this study, there was no difference in risk by type of alcohol consumed, whether wine, beer or liquor.
Based on what we think we know, if you are going to drink, a drink a few times a week may have the least impact on breast cancer. According to an accompanying editorial, alcohol may work by increasing the levels of sex hormones, including estrogen, and we don’t know if stopping diminishes this effect (7).
Does alcohol affect stroke risk?
On the positive side, an analysis of over 83,000 women in the Nurses’ Health Study demonstrated a decrease in the risk of both ischemic (caused by clots) and hemorrhagic (caused by bleeding) strokes with low to moderate amounts of alcohol (8). Those who drank less than a half-glass of alcohol daily were 17 percent less likely than nondrinkers to experience a stroke. Those who consumed one-half to one-and-a-half glasses a day had a 23 percent decreased risk of stroke, compared to nondrinkers.
However, women who consumed more experienced a decline in benefits, and drinking three or more glasses daily resulted in a non-significant increased risk of stroke. The reasons for alcohol’s benefits in stroke have been postulated to involve an anti-platelet effect (preventing clots) and increasing HDL (“good”) cholesterol. Patients should not drink alcohol solely to get stroke protection benefits.
If you’re looking for another option to achieve the same benefits, an analysis of the Nurses’ Health Study recently showed that those who consumed more citrus fruits had approximately a 19 percent reduction in stroke risk (9). The citrus fruits used most often in this study were oranges and grapefruits. Note that grapefruit may interfere with medications such as Plavix (clopidogrel), a commonly used antiplatelet medication used to prevent strokes (10).
Where does this leave us?
Moderation is the key. It is important to remember that alcohol is a drug, and it does have side effects. The American Heart Association recommends that women drink no more than one glass of alcohol a day. Less is better.
For those at high risk of breast cancer, consider forgoing alcohol.
The stroke benefit is tiny, and in some studies, non-existent. Therefore, it’s better to err on the side of caution and minimize your intake.
If you choose to forgo alcohol, the good news is that there are many more appealing, non-alcoholic beverages on the market than there have been in the past.
Dr. David Dunaief is a speaker, author and local lifestyle medicine physician focusing on the integration of medicine, nutrition, fitness and stress management. For further information, visit www.medicalcompassmd.com or consult your personal physician.
New York Cancer & Blood Specialists has announced that Dr. Jahan Aghalar has been recognized as one of Newsweek’s America’s Best Prostate Cancer Oncologists for 2024. This prestigious honor is part of Newsweek’s first annual ranking of America’s Best Prostate Cancer Oncologists & Surgeons, conducted in partnership with Statista.
“We are incredibly proud to have some of the best physicians and disease-specific specialists in the Nation, dedicated to providing world-class cancer care,” said Dr. Jeff Vacirca, Chief Executive Officer of NYCBS. “Dr. Aghalar’s recognition is a reflection of our commitment to excellence and our relentless pursuit of advancing cancer treatment.”
“I am deeply honored to be named among America’s Best Prostate Cancer Oncologists by Newsweek,” said Dr. Aghalar. “This recognition is a testament to the collaborative efforts of my colleagues and the unwavering support from New York Cancer & Blood Specialists. Together, we strive to provide our patients the highest standard of care.”
Dr. Aghalar specializes in malignancies originating from the genitourinary tract, specifically prostate, bladder, kidney, and testicular cancers. For more information, visit nycancer.com or call 631-751-3000.
Iwao Ojima and Martin Kaczocha (foreground) led the Stony Brook team in developing its class of Fatty Acid Binding Proteins (FABPs) a promising set of drug targets for new therapies.
Photo by John Griffin, Stony Brook University
The “FABP” inhibitor is part of a series of compounds that uses the body’s natural marijuana-like substances to curb pain and inflammation
Six years ago Stony Brook University through the Research Foundation for the State University of New York licensed a promising technology to Artelo Biosciences that identified Fatty Acid Binding Proteins (FABPs) as drug targets of the body’s endocannabinoid system for a potentially promising way to treat pain, inflammation and cancer. Now the first one of these compounds has been cleared by the Food and Drug Administration (FDA) for human clinical trials.
Artelo announced this week that the FDA’s initial approval of one of the FABP5 (5 indicates a specific protein) selective compounds called ART26.12 enables the company to initiate its first human phase 1 single ascending dose study of the drug. The company states that ART26.12 will address a critical need for cancer patients, treating chemotherapy-induced peripheral neuropathy. Phase 1 clinical trials are expected to be launched internationally during the first half of 2025.
ART26.12 is the lead compound in the series of FABP5 inhibitors under development. In 2018, Artelo received an exclusive license to the intellectual property of all FABP inhibitors for the modulation of the endocannabinoid system.
The work on FABPs originated with Iwao Ojima, PhD, SUNY Distinguished Professor in the Department of Chemistry at Stony Brook University, Martin Kaczocha, PhD, Associate Professor in the Department of Anesthesiology in the Renaissance School of Medicine at Stony Brook University, and Dale Deutsch, PhD, Professor Emeritus in the Department of Biochemistry and Cell Biology at Stony Brook University, a research collaboration affiliated with the Institute of Chemical Biology and Drug Discovery (ICB & DD). They identified the action of FABPs as drug targets. Specifically, FABP5 was identified as the intracellular transporter for the endocannabinoid anandamide (AEA), a neurotransmitter produced in the brain that binds to cannabinoid receptors.
The research group demonstrated in the laboratory that elevated levels of endocannabinoids can result in beneficial pharmacological effects on stress, pain and inflammation and also ameliorate the effects of drug withdrawal. Drs. Ojima (also Director of the ICB & DD), Kaczocha, Deutsch and colleagues discovered that by inhibiting FABP transporters, the level of AEA is raised. The finding provided the basis for the drug development approach to elevate the levels of AEA.
Artelo took this concept and approach to further develop the compounds. Their scientists collaborated with the Stony Brook team to reach new findings that has led to the commercialization and use of the first drug (ART26.12) in a potential pipeline of drugs to treat pain and inflammation.
After the license to Artelo was finalized, Drs. Ojima and Kaczocha under a contract with Artelo synthesized and evaluated compound candidates with high FABP5 potency and selectivity, an effort that culminated in the development of the lead candidate, SB-FI-1621, which Artelo named ART26.12.
“This is the first clinical stage compound targeting the FABP pathway, an important and exciting milestone,” says Sean Boykevisch, PhD, Director of Intellectual Property Partners in Stony Brook’s Technology Transfer Office. “The fundamental and translational research conducted by the Stony Brook team and their subsequent collaboration with Artelo resulted in a true bench-to-bedside program with the goal of better patient experiences and outcomes.”
“We look forward to sharing the initial clinical results with ART26.12 next year,” says Gregory D. Gorgas, President and CEO of Artelo Biosciences. “As the leading company pursuing FABP inhibition we are committed to building on the unique, lipid-modulating mechanism of our FABP inhibitor platform to address life-altering pathologies for which there are few, if any, safe and effective pharmaceutical treatments.”
For more about the Stony Brook research that developed FABP inhibitors and the grant to support years of research, see this news.
For more details on the FDA clearance news of the drug, and Artelo’s R&D plan, see this news.
New York Cancer & Blood Specialists (NYCBS), recently opened a new state-of-the-art comprehensive cancer center at 1500 Route 112, Building 1 in Port Jefferson Station. The center is approximately 18,000 square feet and just across the parking lot from its previous location in Building 1.
“Our new facility represents a significant step forward in our mission to deliver world-class cancer care,” said Dr. Jeff Vacirca, Chief Executive Officer of NYCBS. “With this new space, we can see even more patients, ensuring everyone receives the timely and comprehensive care they need. This move allows us to provide integrated, patient-centered care in a modern and comfortable setting, reflecting our dedication to improving patient outcomes and experiences.”
According to a press release, the new facility, equipped with cutting-edge technology and expanded services, is designed to enhance patient care and comfort. NYCBS’s experienced oncologists will continue to provide comprehensive cancer care using the latest advancements. The new facility increases capacity, with 33 infusion chairs and 26 exam rooms, ensuring reduced wait times for timely and efficient treatment.
The advanced radiology department offers precise diagnostic imaging, featuring a 64-slice Evo CT scanner and ultrasound capabilities. A unique and significant feature of the new facility is the dedicated wellness suite, established through a partnership with Mondays at Racine. This suite provides free services to patients, such as oncology massage, skincare, and beauty treatments, to support their overall well-being.
For more information, visit nycancer.com or call 631-751-3000.
For the second consecutive year, Myrtle Beach, South Carolina and Wilmington, North Carolina landed the top spot on the list of cities people are moving to. Raleigh, North Carolina jumped 14 places compared to last year, coming in sixth in 2024. However, it’s not just these coastal gems that are seeing an influx of new residents. The entire Southern Appalachian region is booming, with droves of people seeking the “quiet life” in states like Tennessee, Georgia, and Alabama.
Prev
